About Me
Conditions and Treatments
Conditions
- schizophrenia
Treatments
- post covid-19 care
Learn more about conditions we treat at NYU Langone:
SchizophreniaCredentials
Positions
- Marvin Stern Professor of Psychiatry, Department of Psychiatry at NYU Grossman School of Medicine
- Vice Chair, Research, Department of Psychiatry
Board Certifications
- American Board of Psychiatry & Neurology - Psychiatry, 1986
Education and Training
- Fellowship, Tufts Medical Center, Psychiatry, 1985
- Residency, Massachusetts General Hospital, Psychiatry, 1984
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
-
Aetna
- Aetna EPO (AMEX employees)
- Aetna POS (American Express Employer)
-
Anthem Blue Cross Blue Shield
- BCBS EPO (BlackRock Employees)
- BCBS EPO (LICH Employees)
- BCBS EPO - Empire EPO (NYU Langone Employees)
- BCBS EPO - Empire EPO (Sunset Park/Family Health Center Employees)
- BCBS EPO - Empire NYU Care (NYU Langone Employees)
- BCBS EPO - Empire NYU Care (Sunset Park/Family Health Center Employees)
- BCBS PPO (BlackRock Employees)
- BCBS PPO - Empire PPO (Sunset Park/Family Health Center Employees)
-
United Healthcare
- Unite Healthcare (NY University Care Plan)
- United Healthcare Choice (AMEX employees)
- United Healthcare Choice (Blackrock employees)
- United Healthcare Choice (CBS employees)
- United Healthcare Choice (Simon
- United Healthcare EPO (NYU Langone Health Employees)
- United Healthcare Indemnity (NYU Langone Health Employees)
- United Healthcare Nexus (Amex Employees)
- United Healthcare Plus (NYU Langone Health Employees)
- United Healthcare Student Resources (NYU)
- United Healthcare Value, Advantage and HDHP (New York University employees)
Donald C. Goff, MD does not accept insurance.
Locations and Appointments
NYU Langone Psychiatry Associates
1 Park Avenue, 8th Floor, New York, NY 10016
Research Academic Contact
Academic office
One Park Avenue
Eighth Floor
New York, NY 10016
Phone
646-754-4843
Clinical Trials and Research Studies
-
This is a 12-week study of levetiracetam in conjunction with a second generation antipsychotic in early psychosis patients with treatment-resistant symptoms. Treatment with antipsychotics has been shown to be associated with loss of volume in the hippocam
-
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm parallel-group 24-week open-label 7-site clinical trial to examine the effects of treatment with clozapine vs antipsychoti
-
The primary objectives of this study are to examine the tolerability of pulsed low-intensity focused ultrasound (PLIFUS) and its effects on brain function measured via fMRI functional connectivity and symptom response in individuals with schizophrenia. A
Publications
-
McKenna, Faye; Gupta, Pradeep Kumar; Sui, Yu Veronica; Bertisch, Hilary; Gonen, Oded; Goff, Donald C; Lazar, Mariana
Schizophrenia bulletin. 2023 Nov 29; 49(6):1542-1553
-
Qi, Wei; Wen, Zhenfu; Chen, Jingyun; Capichioni, Gillian; Ando, Fumika; Chen, Zhe Sage; Wang, Jijun; Yoncheva, Yuliya; Castellanos, Francisco X; Milad, Mohammed; Goff, Donald C
Schizophrenia research. 2023 Nov ; 261:100-106
-
Qi, Wei; Marx, Julia; Zingman, Michael; Li, Yi; Petkova, Eva; Blessing, Esther; Ardekani, Babak; Sakalli Kani, Ayse; Cather, Corinne; Freudenreich, Oliver; Holt, Daphne; Zhao, Jingping; Wang, Jijun; Goff, Donald C
Schizophrenia bulletin. 2023 Jan 03; 49(1):34-42
Related News
Schizophrenia Major Risk for COVID-19 Death
Research Explores Key Factors in the Schizophrenic Brain